Prosecution Insights
Last updated: August 06, 2026

Wuhan University

6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (67%)
2
Medium (33%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (50%)
§103 only2 (33%)
Multi-statute (no §101)1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
17% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JOHNSON, EMILY KATHARINE 1 83.3% +27.8%
XING, CHRISTINA ILONA 1 88.6% +8.3%
YU, DELPHINUS DOU YI 1 50.0% +0.0%
MUMMERT, STEPHANIE KANE 1 60.8% +21.8%
OYEYEMI, OLAYINKA A 1 60.7% +46.1%
SAMSELL, RILLA MARIE 1 73.1% +13.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18822459 DEVICE, SYSTEM, AND METHOD FOR IN-SITU MEASUREMENT OF THREE-DIMENSIONAL MORPHOLOGY OF MELT POOLS XING, CHRISTINA ILONA 30d overdue

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17708005 METHOD OF DIAGNOSING AND MONITORING SUBSTANCE ADDICTION OR BEHAVIORAL ADDICTION USING C-KIT BIOMARKER OYEYEMI, OLAYINKA A 49d overdue
17709358 USE OF COMPOSITION OF IMATINIB OR DERIVATIVE THEREOF IN PREPARATION OF DRUG FOR PREVENTING, TREATING, AND CONTROLLING ADDICTION RELAPSE SAMSELL, RILLA MARIE 31d overdue
18983398 HIGH-YIELD AND LARGE PANICLE GENE OLGN8.2 FROM WILD RICE ORYZA LONGISTAMINATA AND APPLICATIONS THEREOF JOHNSON, EMILY KATHARINE
18277768 EDITING OF DOUBLE-STRANDED DNA WITH RELAXED PAM REQUIREMENT YU, DELPHINUS DOU YI

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17708005 METHOD OF DIAGNOSING AND MONITORING SUBSTANCE ADDICTION OR BEHAVIORAL ADDICTION USING C-KIT BIOMARKER OYEYEMI, OLAYINKA A 49d overdue
17709358 USE OF COMPOSITION OF IMATINIB OR DERIVATIVE THEREOF IN PREPARATION OF DRUG FOR PREVENTING, TREATING, AND CONTROLLING ADDICTION RELAPSE SAMSELL, RILLA MARIE 31d overdue
18105233 MOLECULAR BEACON BASED NANOPROBES FOR DIRECTLY DETECTING ORGAN-SPECIFIC MATASTASIS RELATED BIOMARKERS OF TUMOR CELLS IN PERIPHERAL BLOOD, PREPARATION METHOD AND APPLICATION MUMMERT, STEPHANIE KANE 83d
18983398 HIGH-YIELD AND LARGE PANICLE GENE OLGN8.2 FROM WILD RICE ORYZA LONGISTAMINATA AND APPLICATIONS THEREOF JOHNSON, EMILY KATHARINE

Top Art Units

Art UnitApps
1681 2
1662 1
2877 1
1636 1
1624 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18983398 HIGH-YIELD AND LARGE PANICLE GENE OLGN8.2 FROM WILD RICE ORYZA LONGISTAMINATA AND APPLICATIONS THEREOF JOHNSON, EMILY KATHARINE 1662 §101§102§103§112 Non-Final OA Pending Dec 17, 2024
18822459 DEVICE, SYSTEM, AND METHOD FOR IN-SITU MEASUREMENT OF THREE-DIMENSIONAL MORPHOLOGY OF MELT POOLS XING, CHRISTINA ILONA 2877 §103 Non-Final OA 30d overdue Pending Sep 02, 2024
18277768 EDITING OF DOUBLE-STRANDED DNA WITH RELAXED PAM REQUIREMENT YU, DELPHINUS DOU YI 1636 §102§103Other Non-Final OA Pending Aug 17, 2023
18105233 MOLECULAR BEACON BASED NANOPROBES FOR DIRECTLY DETECTING ORGAN-SPECIFIC MATASTASIS RELATED BIOMARKERS OF TUMOR CELLS IN PERIPHERAL BLOOD, PREPARATION METHOD AND APPLICATION MUMMERT, STEPHANIE KANE 1681 §103 Final Rejection 83d Pending Feb 02, 2023
17708005 METHOD OF DIAGNOSING AND MONITORING SUBSTANCE ADDICTION OR BEHAVIORAL ADDICTION USING C-KIT BIOMARKER OYEYEMI, OLAYINKA A 1681 §101§102§103§112 Non-Final OA 49d overdue Pending Mar 30, 2022
17709358 USE OF COMPOSITION OF IMATINIB OR DERIVATIVE THEREOF IN PREPARATION OF DRUG FOR PREVENTING, TREATING, AND CONTROLLING ADDICTION RELAPSE SAMSELL, RILLA MARIE 1624 §101§102§103§112 Final Rejection 31d overdue Pending Mar 30, 2022

Managing Wuhan University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month